Author

Jana Bagarova

Brigham and Women's HospitalORCID 0009-0007-8552-5787Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:mouse· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Paul B. YuiD· 2 shared Agustin H. Mohedas· 1 shared Alex N. BullockiD· 1 shared Aris N. EconomidesiD· 1 shared Arthur M. LeeiD· 1 shared Devaveena DeyiD· 1 shared Dong-Dong Xia· 1 shared Eleanor WilliamsiD· 1 shared

Activity by Year

2021-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCell Biology

Paul B. YuORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cell BiologybioRxivPreprintDec 26, 2025

BMP9-mediated regulation of endothelin-1 requires integrated SMAD1/5 and SMAD2/3 signaling

Jana Bagarova, Shreya Sangam, Luca Troncone…·Paul B. Yu

This study shows BMP9 regulates ET-1 through coordinated SMAD1/5 and SMAD2/3 signaling in endothelial cells, revealing a non-canonical mechanism relevant to pulmonary arterial hypertension.

1 citation

humanmouse

𝕏 PostBluesky

Molecular BiologyJCI InsightPeer-reviewedMar 11, 2021

Saracatinib is an efficacious clinical candidate for fibrodysplasia ossificans progressiva

Eleanor Williams, Jana Bagarova, Georgina Kerr…·Alex N. Bullock

The paper identifies saracatinib as a potent ALK2 inhibitor effective in preventing heterotopic ossification in FOP models.

73 citationstop 1%

mouseexperimental assay

𝕏 PostBluesky